Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Resmed (NYSE: RMD) announced that chairman and CEO Mick Farrell and CFO Aaron Bloomer will participate in the 24th Annual Morgan Stanley Global Healthcare Conference in New York on September 15, 2026. A live, audio-only webcast of Resmed’s presentation will begin at approximately 10:00 a.m. Eastern Time, with a replay available for about 90 days via the company’s investor relations website.

Market Context

The prior -5.06% reaction to RMD's FY2026 earnings announcement adds context to this conference part...

Analysis

The prior -5.06% reaction to RMD's FY2026 earnings announcement adds context to this conference participation notice. Recent insider activity was net selling, a sourced risk; investors could monitor the eventual presentation for new operating information.

Key Figures

Conference edition: 24th annual Conference date: September 15, 2026 Webcast start: approximately 10:00 a.m. (Eastern Time) +3 more

6 metrics

Conference edition 24th annual Morgan Stanley Global Healthcare Conference

Conference date September 15, 2026 New York, NY

Webcast start approximately 10:00 a.m. (Eastern Time) Resmed webcast presentation

Replay availability approximately 24 hours After the live webcast ends

Replay access period 90 days Following webcast replay availability

Countries served 140 countries Company description

Historical Context

5 past events · Latest: Aug 25 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 25	Sleep-apnea partnership	Positive	+1.8%	Collaboration promoted sleep-apnea awareness and highlighted CPAP treatment
Aug 17	Director transition	Neutral	-0.2%	Carol Burt became lead director ahead of Ron Taylor’s retirement
Aug 06	Q4 FY2026 earnings	Positive	-5.1%	Revenue, margins, earnings, cash flow, and capital returns increased
Jul 07	MatrixCare sale agreement	Neutral	-6.3%	Frazier Healthcare Partners agreed to acquire MatrixCare from Resmed
Jul 07	MatrixCare sale agreement	Neutral	-6.3%	Resmed agreed to sell MatrixCare to Frazier Healthcare Partners

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history showed negative reactions to two positive or strategic announcements, while the sleep-apnea partnership was followed by a positive reaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026. Resmed’s webcast presentation will begin at approximately 10:00 a.m. (Eastern Time).

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investors	For media
+1 858.221.3304	+1 619.510.1281
investorrelations@resmed.com	news@resmed.com

FAQ

When will Resmed (RMD) present at the 24th Annual Morgan Stanley Global Healthcare Conference?

Resmed will present at the 24th Annual Morgan Stanley Global Healthcare Conference on September 15, 2026, at approximately 10:00 a.m. Eastern Time. According to Resmed, this event takes place in New York, NY and features a live, audio-only webcast for investors.

Which Resmed (RMD) executives are attending the 2026 Morgan Stanley Global Healthcare Conference?

Resmed states that Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference. According to Resmed, both leaders will participate in the company’s webcast presentation for investors.

How can investors access the Resmed (RMD) webcast from the 2026 Morgan Stanley Global Healthcare Conference?

Investors can access Resmed’s live, audio-only webcast by visiting https://investor.resmed.com. According to Resmed, more information about the event and the webcast link will be available on the investor relations site for convenient online access.

Will a replay of Resmed’s (RMD) 2026 Morgan Stanley conference webcast be available to investors?

Yes, a replay of Resmed’s audio-only webcast will be available about 24 hours after the live event ends. According to Resmed, this replay will remain accessible for approximately 90 days through the company’s investor relations website.

What time zone is used for Resmed’s (RMD) 10:00 a.m. webcast at the Morgan Stanley Global Healthcare Conference?

Resmed’s webcast presentation is scheduled for approximately 10:00 a.m. Eastern Time on September 15, 2026. According to Resmed, investors should reference Eastern Time when planning to listen to the live, audio-only conference webcast online.

Where is the 24th Annual Morgan Stanley Global Healthcare Conference with Resmed (RMD) being held?

According to Resmed, the 24th Annual Morgan Stanley Global Healthcare Conference will be held in New York, NY. Investors who cannot attend in person can listen through Resmed’s live, audio-only webcast and subsequent replay via the company’s investor relations website.